Influenza A H1N1 BY PCR

The Influenza A H1N1 BY PCR is a molecular diagnostic test that detects the presence of Influenza A (H1N1) viral RNA in respiratory specimens using real-time polymerase chain reaction. This highly sensitive and specific method identifies active infection, enabling early and accurate diagnosis compared with antigen or antibody tests.

It is used to confirm suspected H1N1 infection in symptomatic patients, screen close contacts or high-risk individuals, and support clinical decisions on antiviral therapy and isolation to limit transmission. Results are delivered securely to patients and treating clinicians in Dubai to facilitate timely treatment and public health reporting when required.

• Influenza A (H1N1) viral RNA — qualitative
• Influenza A subtyping (H1N1)
• Cycle threshold (Ct) value (reporting for laboratory reference)

• Within 1–7 days of acute onset of fever and respiratory symptoms
• New cough, sore throat, or difficulty breathing
• After close contact with a confirmed influenza H1N1 case
• Prior to hospital admission or procedures when respiratory infection is suspected
• During local outbreaks or increased community transmission

• High diagnostic accuracy for detecting active H1N1 infection
• At-home sample collection by trained healthcare professionals
• Rapid turnaround to guide timely antiviral treatment and isolation
• Reduces exposure by avoiding clinic or hospital visits
• Secure electronic reporting suitable for UAE healthcare follow-up

• Nasopharyngeal and/or oropharyngeal swab collected by a trained professional
• No fasting or special preparation required
• Preferably performed within the first week of symptom onset for highest sensitivity
• Valid Emirates ID and contact details available for reporting and clinical follow-up